Anti-Human APRIL,A206,Leinco
Product Type: Polyclonal Antibody
Alternate Names: A Proliferating-Inducing
Ligand, CD256, TNFSF13, TALL2, TRDL1
Applications: ELISA Indirect, FC, WB
Prod No.
|
Size
|
Price
|
Avail.
|
Qty
|
Add to cart
|
|
|
|
|
|
|
|
|
|
|
|
|
Antibody Details
Immunogen
Purified Recombinant Human APRIL (>98%)
Endotoxin Level
<0.1 EU/μg as determined by the LAL method
Formulation
This antigen affinity purified polyclonal antibody has been 0.2 μm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present.
Storage and Handling
The lyophilized antigen affinity purified polyclonal antibody can be stored desiccated at -20°C to -70°C for twelve months from date of receipt. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody, aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. No detectable loss of activity was observed after six months.
Description
Specificity
Rabbit Anti-Human A Proliferating-Inducing Ligand (APRIL) recognizes Human APRIL. This antigen affinity purified polyclonal antibody was purified using a proprietary chromatographic technique that includes covalently immobilizing the antigen proteins or peptides to agarose based beads. This purification method enhances specificity, reduces nonspecific binding of extraneous IgG and provides you with the most reliable reagent available for your early discovery research.
Background
A proliferation-inducing ligand (APRIL) is a TNF-like cytokine that stimulates tumor cell growth.1 It is of low abundance in normal tissues.2 APRIL acts as a proliferative factor in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation.3 APRIL may be implicated in the regulation of tumor cell growth.2
Antigen Details
References & Citations
1. Hymowitz, SG. et al. (2004) J Mol Biol. 343: 283
2. Tschopp, J. et al. (1998) J Exp Med. 188(6):1185-90.
3. De Maria, R. et al. (2004) Blood 104: 3169
Technical Protocols